Kathleen Ehrhard was a featured panelist at the Association for Corporate Growth (ACG) February Biotech Breakfast meeting. The meeting focused on investment in the biotechnology industry. She addressed IP/IT legal issues, recent developments and trends for private equity and venture capital investment and biotech product development.
2.10.2017